Elite Pharma Valuation
| ELTP Stock | USD 0.45 0.07 18.42% |
Elite Pharma is overvalued. Elite Pharma shows a prevailing Real Value of $0.41 per share. The current price of the firm is $0.45. Our model computes the value of Elite Pharma from reviewing the firm fundamentals such as Shares Outstanding of 1.01 B, current valuation of 27.92 M, and Profit Margin of 0.20 % as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise buying undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Elite Pharma's price fluctuation is out of control at this time. Calculation of the real value of Elite Pharma is based on 3 months time horizon. Increasing Elite Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Elite otc stock is determined by what a typical buyer is willing to pay for full or partial control of Elite Pharma. Since Elite Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elite OTC Stock. However, Elite Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.45 | Real 0.41 | Hype 0.45 | Naive 0.42 |
The intrinsic value of Elite Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Elite Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Elite Pharma helps investors to forecast how Elite otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elite Pharma more accurately as focusing exclusively on Elite Pharma's fundamentals will not take into account other important factors: About Elite Pharma Valuation
The otc valuation mechanism determines Elite Pharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Elite Pharma based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Elite Pharma. We calculate exposure to Elite Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elite Pharma's related companies.Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey. Elite Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 43 people.
8 Steps to conduct Elite Pharma's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Elite Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Elite Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Elite Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Elite Pharma's revenue streams: Identify Elite Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Elite Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Elite Pharma's growth potential: Evaluate Elite Pharma's management, business model, and growth potential.
- Determine Elite Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Elite Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Elite Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Elite Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1 B | |
| Quarterly Earnings Growth Y O Y | 0.098 | |
| Retained Earnings | -140.1 M |
Additional Tools for Elite OTC Stock Analysis
When running Elite Pharma's price analysis, check to measure Elite Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elite Pharma is operating at the current time. Most of Elite Pharma's value examination focuses on studying past and present price action to predict the probability of Elite Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elite Pharma's price. Additionally, you may evaluate how the addition of Elite Pharma to your portfolios can decrease your overall portfolio volatility.